@article{article, title  = {{Pharmacokinetics (PK) and safety of tralokinumab in children (aged 6 to <12 years) with moderate-to-severe atopic dermatitis: an interim analysis of the TRAPEDS 1 phase 2 trial}},

 publisher = {{Elsevier BV}},

 url = {{https://doi.org/10.1016/s0022-202x(26)00604-4 }},

 year = {{2026}},

 month = {{3}},

 author = {{Cork M and de Graaf M and Torres EB and Pasmans S and Reguiai Z and Kurvits M and Lo H and Schneider S and Søhoel A and Thøgersen P and Flohr C et al}},

 doi = {{10.1016/s0022-202x(26)00604-4}},

 volume = {{146}},

 journal = {{Journal of Investigative Dermatology}},

 issue = {{3}},

 pages = {{S17-S17}},

 note = {{Accessed on 2026/03/16}}}